晟德大藥廠股份有限公司

晟德大藥廠股份有限公司 is a declared insider of 益安, with filings sourced from TWSE / TPEx (MOPS). We count 3 filings; the first trade dates from 30 January 2026 and the latest from 2 October 2026.

The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The newest entry dates from 2 October 2026: a transaction, in 益安. Most trades are made public on the day they happen. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from TWSE / TPEx (MOPS) disclosures alone and does not predict where the share price will go.